Curatis Holding Ltd

CURN

Equity

ISIN CH1330780979 / Valor 133078097

SIX Swiss Exchange (2024-11-21)

CHF 14.05-6.33%

Curatis Holding Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Curatis Holding Ltd is a Swiss-based pharmaceutical company specializing in the acquisition, licensing, distribution, and promotion of medicines for the treatment and prevention of orphan and specialty diseases. The company holds exclusive distribution rights for over 30 different drugs within Switzerland, many of which target rare and specialized medical conditions. Curatis is actively working to expand its market presence by securing distribution rights in major European markets, including Germany, France, the UK, and Italy. In the medium to long term, the company plans to launch its own products pending regulatory approval. Curatis' growth strategy is bolstered by its aim to increase visibility and funding opportunities through potential public listing. The executive management team, including CFO Patrick Ramsauer, brings extensive experience in finance and corporate governance, further supporting the company's strategic objectives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2,333,233%1Y

18,321%3Y

82,253%5Y

Performance

145%1Y

145%3Y

145%5Y

Volatility